Revelation Biosciences (REVB) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts REVB Hot Sheet
Join SI Premium – FREE
Revelation Biosciences (NASDAQ: REVB) reported Q2 EPS of ($0.87), $0.04 worse than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Revelation Biosciences (REVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
- Boeing wins $13.4 billion contract modification from US military
- BetterLife Pharma files final prospectus for $100M public offering
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
